MARC Record from marc_columbia

LEADER: 03489cam a22004694a 4500
001 5465285
005 20221110042451.0
008 050729s2006 flua b 001 0 eng
010 $a 2005052899
015 $aGBA574057$2bnb
016 7 $a101254239$2DNLM
016 7 $a013283735$2Uk
020 $a0824727312 (hardcover : alk. paper)
024 3 $a9780824727314
029 1 $aNLM$b101254239
035 $a(OCoLC)ocm61254022
035 $a(NNC)5465285
035 $a5465285
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dUKM$dC#P$dOrLoB-B
042 $apcc
050 00 $aQR400.2.H47$bH475 2006
060 00 $aW1$bIN406HMN v.36 2006
060 10 $aWC 578$bH5637 2006
082 00 $a616.9/112$222
245 00 $aHerpes simplex viruses /$cedited by Marie Studahl, Paola Cinque, Tomas Bergström.
260 $aBoca Raton :$bTaylor & Francis,$c2006.
300 $axiii, 420 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aInfectious disease and therapy ;$v36
504 $aIncludes bibliographical references and index.
505 00 $gSect. I.$tUnderstanding and diagnosing herpes simplex virus -- $g1.$tEvolution of herpes simplex viruses /$rRory J. Bowden and Duncan J. McGeoch -- $g2.$tHerpes simplex virus vaccines and the viral strategies used to evade host immunity /$rLauren M. Hook and Harvey M. Friedman -- $g3.$tThe natural history and epidemiology of herpes simplex viruses /$rAndre J. Nahmias, Francis K. Lee and Susanne Beckman-Nahmias -- $g4.$tPathogenesis /$rTomas Bergstrom -- $g5.$tUnderstanding and diagnosing herpes simplex virus /$rEva Thomas -- $gSect. II.$tDisease manifestations of HSV and treatment -- $g6.$tAntiviral treatment /$rGerald Kleymann -- $g7.$tPrimary herpes simplex gingivostomatitis and recurrent orolabial infection /$rJacob Amir -- $g8.$tHerpesvirus infections of the skin /$rKaran K. Sra, Gisela Torres and Stephen K. Tyring -- $g9.$tAcute and recurrent genial herpes simplex virus infection /$rGeorge Kinghorn -- $g10.$tHerpes simplex viruses ocular disease /$rThomas J. Liesegang -- $g11.$tHerpes simplex encephalitis and other neurological syndromes caused by Herpes simplex virus-1 /$rMarie Studahl and Birgit Skoldenberg -- $g12.$tNeurological disease in herpes simplex virus type 2 (HSV-2) infection /$rElisabeth Aurelius -- $g13.$tHerpes simplex virus and Bell's palsy /$rYasushi Furuta -- $g14.$tHerpes simplex virus infections in immunocompromised patients /$rFulvio Crippa and Paola Cinque -- $g15.$tNeonatal herpes simplex virus infection /$rKevin S. Buckley, David W. Kimberlin and Richard J. Whitley -- $g16.$tFuture outlooks /$rTomas Bergstrom, Paola Cinque and Marie Studahl.
650 0 $aHerpes simplex virus.$0http://id.loc.gov/authorities/subjects/sh85060455
650 12 $aHerpes Simplex.$0https://id.nlm.nih.gov/mesh/D006561
650 22 $aHerpes Simplex Virus Vaccines.$0https://id.nlm.nih.gov/mesh/D022301
650 22 $aHerpesvirus 1, Human.$0https://id.nlm.nih.gov/mesh/D018259
650 22 $aHerpesvirus 2, Human.$0https://id.nlm.nih.gov/mesh/D018258
700 1 $aStudahl, Marie.$0http://id.loc.gov/authorities/names/n2005183228
700 1 $aCinque, Paola.$0http://id.loc.gov/authorities/names/n2005183229
700 1 $aBergström, T.$q(Tomas)$0http://id.loc.gov/authorities/names/n98802472
830 0 $aInfectious disease and therapy ;$vv. 36.$0http://id.loc.gov/authorities/names/n86726266
852 00 $boff,hsl$hQR400.2.H47$iH475 2006